On September 12, L’Oréal announced the signing of a tripartite partnership with Abolis Biotechnologies, a biotechnology company, and Evonik, a leader in specialty chemicals. This partnership aims to accelerate the development and large-scale production of next-generation bio-based ingredients. The collaboration aligns with L’Oréal’s L’Oréal for the Future program, which promotes the introduction of sustainable ingredients in beauty products.
This agreement is an important foundation for speeding up the process from research and development to market introduction, enabling L’Oréal to meet the global demand for sustainable beauty products. Through this collaboration, L’Oréal has moved closer to its goal of using bio-based ingredients in 95% of its products by 2030.
L’Oréal and Evonik have invested in Abolis, a French biotechnology company that provides industrial solutions using microorganisms. This partnership will allow Abolis to expand its capabilities and apply its microbial technology not only in the cosmetics industry but also in the medical and nutritional sectors.
Barbara Lavernos, Deputy Chief Executive Officer in charge of Research, Innovation and Technology, L’Oréal Groupe commented: “We are proud to invest in Abolis and expand our collaboration, working together as a tight ecosystem alongside our historical partner, Evonik. By mobilizing our respective companies’ research, innovation and manufacturing capabilities and expertise, we are building an end-to-end value chain that we believe has tremendous potential to be a game-changer in bio-based ingredients for beauty.”
Cyrille Pauthenier, CEO of Abolis, said, “We are thrilled to receive this round of funding which will allow us to take the next step in pushing the boundaries of innovation in biotechnology.” He continued, “Our collaboration with L’Oréal and Evonik will empower us to create groundbreaking solutions tailored to drive the sustainable transformation of the industries we serve including beauty, nutrition and healthcare.”
Ute Schick, Head of the Care Solutions Business Line at Evonik, added, “We are honored to be selected by L’Oréal as their industrial-scale manufacturer of choice for this endeavor, building on a long-standing and expanded relationship between Evonik and L’Oréal. We are excited to be part of bringing new, blockbuster sustainable ingredients to the global market alongside L’Oréal and Abolis.”
This collaboration between the three companies marks an important step not only for the beauty industry but also in advancing sustainable innovation.